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Filamentous fungi are the predominant source of lignocellulolytic enzymes used in
industry for the transformation of plant biomass into high-value molecules and biofuels.
The rapidity with which new fungal genomic and post-genomic data are being produced
is vastly outpacing functional studies. This underscores the critical need for developing
platforms dedicated to the recombinant expression of enzymes lacking confident
functional annotation, a prerequisite to their functional and structural study. In the last
decade, the yeast Pichia pastoris has become increasingly popular as a host for the
production of fungal biomass-degrading enzymes, and particularly carbohydrate-active
enzymes (CAZymes). This study aimed at setting-up a platform to easily and quickly
screen the extracellular expression of biomass-degrading enzymes in P. pastoris. We
first used three fungal glycoside hydrolases (GHs) that we previously expressed using
the protocol devised by Invitrogen to try different modifications of the original protocol.
Considering the gain in time and convenience provided by the new protocol, we
used it as basis to set-up the facility and produce a suite of fungal CAZymes (GHs,
carbohydrate esterases and auxiliary activity enzyme families) out of which more than
70% were successfully expressed. The platform tasks range from gene cloning to
automated protein purifications and activity tests, and is open to the CAZyme users’
community.
Keywords: recombinant proteins, expression platform, CAZymes, Pichia pastoris, factorial approach, automation,
glycoside hydrolase
Introduction
Lignocellulosic biomass is recognized as a sustainable source of mixed sugars for producing
second generation biofuels by fermentation, and for the synthesis of biomaterials (Lynd et al.,
2008). In industry, sacchariﬁcation of lignocellulose is performed enzymatically using fungal
enzyme cocktails (Himmel et al., 2007). Due to the recalcitrant nature of lignocellulosic
biomass, the development of more eﬃcient fungal enzyme preparations is an active research
ﬁeld with the sequencing of hundreds of fungal genomes at the US Department of Energy
Joint Genome Institute 1,000 fungal genome project, (Grigoriev et al., 2014). This wealth
Abbreviations: AA, auxiliary activities; CAZy, carbohydrate-active enzymes; CE, carbohydrate esterase; GH, glycoside
hydrolase; kDa, kiloDalton; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis.
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of genomic information opens new horizons and opportunities
to improve the enzymatic conversion of biomass.
However, due to throughput diﬀerences the production
of recombinant fungal proteins lags far behind that of data
generated by –omic approaches, which creates a bottleneck
in the process of unraveling the function of novel CAZymes.
Although historically ﬁlamentous fungi (e.g., Trichoderma reesei,
Aspergillus niger) and other yeast (e.g., Saccharomyces cerevisiae,
Yarrowia lipolytica) have been used for expressing native or
recombinant fungal enzymes (Dashtban et al., 2009), the yeast
Pichia pastoris has become the premier example of yeast species
used for the production of recombinant proteins (Cregg et al.,
2000; Damasceno et al., 2012). Advantages of this yeast include
the use of eﬃcient and tightly regulated promoters, higher
expression levels for lower cost than insect and mammalian
cells. Compared to prokaryotic expression, it provides better
protein folding, allows post-translational modiﬁcations (N- and
O-glycosylation, methylation, and acylation), and is able to
secrete high levels of recombinant proteins in the culture
medium. In addition, it secretes very low levels of endogenous
proteins none of which has been reported to be active on
lignocellulosic biomass, which simpliﬁes protein puriﬁcation.
Finally, because ﬁlamentous fungi and yeast are
phylogenetically close, P. pastoris is the organism of choice
for expressing diﬀerent classes of active fungal CAZymes, such as
GHs (Bauer et al., 2006; Couturier et al., 2011a,b), CE (Topakas
et al., 2010, 2012) and AA enzymes [i.e., lytic polysaccharide
mono-oxygenases (Kittl et al., 2012; Bey et al., 2013)]. Having
these many advantages over other expression systems makes
P. pastoris an organism of choice for the production of industrial
enzymes (Rabert et al., 2013).
Despite obvious advantages, we have found that heterologous
expression of fungal enzymes in P. pastoris remained time-
consuming, and reasoned that protocols for transformation,
screening of transformants, cultures, puriﬁcation of recombinant
proteins could beneﬁt from streamlining to try to increase
protein production-throughput. In this study, we have used in-
house fungal genes encoding CAZymes [GH5, GH11, GH45
(Couturier et al., 2011a,b)] that we previously successfully
expressed in P. pastoris using pPICZα inducible vector, to
establish a simpler standard protocol. In this paper, we have
analyzed, and modiﬁed whenever possible, diﬀerent steps of
the protocol set-up by Invitrogen for expressing proteins
in P. pastoris from the design of expression constructs to
the assay of puriﬁed proteins, with the ultimate goal of
setting-up a lab-scale recombinant protein production facility.
This platform now makes the link between upstream expert
annotation of CAZymes (www.cazy.org) (Lombard et al., 2014)
and downstream automated assay of enzymatic activities (Lafond
et al., 2012) and crystallogenesis (Sulzenbacher et al., 2002).
Materials and Methods
Enzymes
Taq (screening purpose) and Platinum pfx (cloning purpose)
DNA polymerases (Invitrogen) were used in PCR experiments.
Expression Constructs
Coding sequences to express were PCR ampliﬁed, and then
inserted into Invitrogen vectors pPICZαA (Couturier et al.,
2011a,b), pGAPZαA and pBGP1 (Sasagawa et al., 2011) (this
study) inframe with N-terminal yeast α-secretion factor and
C-terminal His6 tag encoding sequences. Plasmid pBGP1 was
obtained by removing the Gateway cassette from pBGP1-DEST
(Sasagawa et al., 2011) by XhoI/XbaI restriction digestion. The
primers used were: GGGGCTAAAGAACTCGAGAAAAGAG
AGGCTGAAGCTCTCCCCCAAGCACAAGGTG and TTTTC
TAGACCCGCCGGGAGAGCATTGATAG for Podospora
anserine GH5 (GenBank: HM357135.1), GGGGCTAAAGAA
CTCGAGAAAAGAGAGGCTGAAGCTGCCCCCGGTGAGCT
TCCT and TTTTCTAGACCGTGTGTCTGGACATAAATGTC
for P. anserine GH11 (GenBank: HM357137.2), and GGGGCTA
AAGAACTCGAGAAAAGAGAGGCTGAAGCTGATGTCCCA
CTTTGGGGCCAATG and TCTAGACCTTCGTCCGTACGAG
CACA for P. pastoris GH45 (GenBank: CAY71902.1). Except
pBGP1, resulting recombinant expression plasmids were
linearized with PmeI (pPICZαA) or AvrII (pGAPZαA) restriction
enzymes.
Preparation of Frozen Electrocompetent Cells
and Transformation
Cells were grown as described by Invitrogen
(easyselect_man.pdf) with the following modiﬁcation: when
OD600 was about 1.4, cells recovered from 250 ml culture were
resuspended in 100 ml YPD supplemented with 20 ml 1 M
HEPES pH8 and 2.5 ml 1 M DTT, and stored at 30◦C for 15’.
After washing as described in easyselect_man.pdf, they were
eventually resuspended in 0.5 ml of cold 1 M sorbitol and 60 μl
aliquots were frozen at −80◦C.
Electroporation was performed as described in
easyselect_man.pdf using 60 μl of thawed electrocompetent
cells.
Liquid Phase Selection and Expression
Screening
General Strategy
Both were performed in 24-wells deepwell plates. Indicated
volumes are for one well. An aliquot (200 μl) of sorbitol cell
suspension was used to inoculate 2 ml YPD supplemented with
100 μg/ml Zeocin, which was then incubated for 3 days at 30◦C
under 225 rpm rotary shaking. This step has two aims: it selects
transformed cells as do Zeocin-containing agar plates, and serves
as a pre-culture for the following recombinant protein expression
screening. The latter was performed by inoculating 5 ml Zeocin-
free growth medium with 50 μl pre-culture and then incubating
at 30◦C under shaking. At the end of the expression period,
culture supernatants were recovered by centrifugation for 5’ at
4000 g and their protein content analyzed by SDS-PAGE and/or
enzymatic activity assay.
Constitutive Expression (pGAPZαA)
Protein expression screening was performed by inoculating 5 ml
YPD with 50 μl pre-culture and then incubating for 4 days at
30◦C under shaking.
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Inducible expression (pPICZαA)
Protein expression screening was performed by inoculating 5 ml
BMGY (easyselect_man.pdf) with 50 μl pre-culture, and then
incubating overnight at 30◦C under shaking. The plate was then
spun as above and the cell pellet was resuspended in 1 ml
BMMY (easyselect_man.pdf). The culture medium was daily
supplemented with 3% methanol for 4 days.
Automated Purification of Recombinant
Proteins
Non-Automated Pre-Purification Steps
(i) At the end of the expression period, 24-wells deepwell plates
were spun for 5’ at 4000 g to pellet the cells. Supernatants
were transferred well to well to another 24-wells deepwell
plate, and each well was supplemented with 1/10 supernatant
volume of 250 mM Tris pH8. (ii) Two hundred microliters of
a 50% suspension of Ni SepharoseTM High Performance (GE
Healthcare 17-5268-02) were loaded into each well of a 96-wells
deepwell ﬁlter plate (AcroPrepTM Advance 1 ml, 1 μm Glass
Fiber, PALL PN 8131). (iii) 24-wells deepwell plates containing
the supernatants were put on a TECAN Freedom Evo robot, and
the 96-wells deepwell ﬁlter plate on the ﬁrst manifold of the same
robot (Navarro et al., 2010).
Automated Steps
Indicated volumes are for one well. The automate removed
ethanol from Sepharose beads by vacuum aspiration for 30′′ at
−50 millibars (mb), and then added 200 μl buﬀer A (10 mm Tris
pH7.8, 150 mM NaCl and 10 mM imidazole). After 2′, buﬀer A
was eliminated by vacuum aspiration for 30′′ at −50 mb. This
step was repeated once. The robot transferred 800 μl of each
culture supernatant from the 24-wells deepwell plate to each
well of the 96-wells deepwell ﬁlter plate. After 3′ incubation,
the supernatant was eliminated by vacuum aspiration for 60′′ at
−50 mb. If more than 1 ml supernatant was to be processed, this
step was repeated the required number of times. At the end of
the binding step, the robot washed the beads twice with buﬀer
A as above, and then dried them by an additional 5′′ −700 mb
vacuum aspiration. The robot transferred the ﬁlter plate on top of
a 96-wells microplate that had been put on the second manifold
of the robot beforehand, and added 200 μl buﬀer B (10 mm Tris
pH7.8, 150 mM NaCl and 500 mM imidazole) to each well of the
ﬁlter plate. After 5′ incubation, the robot transferred the elution
volume from each well of the ﬁlter plate to the corresponding well
of the 96-wells microplate underneath by two successive vacuum
aspirations for 20′′ at −50 mb. Complete recovery of elution
volume was achieved by performing a second vacuum aspiration
for 5′′ at −700 mb. The ﬁlter plate was then transferred back to
the ﬁrst manifold where beads were regenerated by performing
the following operations. (i) Buﬀer B (200 μl) was added and
after 2′ incubation removed by vacuum aspiration for 30′′ at
−50 mb. This step was repeated once. (ii) Buﬀer A (200 μl) was
added and after 2′ incubation removed by vacuum aspiration
for 30′′ at −50 mb. (iii) Finally, beads were supplemented in
400 μl of 20% ethanol. The ﬁlter plate was sandwiched between
two adhesive aluminum sheets (Dutscher reference 106524) and
stored at 4◦C.
Enzymatic Activity Assays
Indicated volumes are for one well. GH5, GH11, and GH45
enzymatic activities were assayed by measuring the hydrolysis
of 1% azo-glucomannan, azo-xylan, and azo-CM-cellulose
(Megazyme), respectively. The assay is based on GH-dependent
hydrolysis of a dyed substrate that produces low-molecular
weight dyed fragments which remain in solution on addition of a
precipitant solution. High-molecular weight material is removed
by centrifugation and the color of the supernatant is measured.
In practice, culture supernatants or puriﬁed enzymes (10 μl)
were added to 50 μl of azo-substrate solution in 50 mM sodium
acetate pH4.8 in 96-well plates. The latter were heat-sealed with
aluminum sheet using the robot PlateLoc sealer, and incubated
at 40◦C for 2 h under 800 rpm rotary shaking. Ethanol (150 μl)
was added to precipitate non-hydrolysed substrate. After 10′
at room temperature, plates were centrifuged at 4000 g for 5′.
Supernatants were collected and their optical density measured at
590 nm. Activities were expressed as percentage of azo-substrate
used. The 100% value was the OD590 of a well to which no ethanol
and no enzyme had been added.
Results and Discussion
In a previous work, three GH (GH5, GH11, and GH45) were
successfully expressed in P. pastoris by strictly following the
protocol proposed by Invitrogen (easyselect_man.pdf). Analysis
of the original protocol resulted in a list of diﬀerent steps that
could be subject of optimization in terms of time, cost, or
convenience. The list was made of: (1) using frozen competent
cells instead of extemporaneously preparing competent cells; (2)
using less plasmid for electroporation; (3) skipping the selection
of recombinant clones on plate; (4) replacing tubes and ﬂasks
with deep-well plates in the screening process. In addition to
simplifying the original protocol, the puriﬁcation of secreted
His-tagged proteins was automated to increase throughput.
Expression Constructs
In a ﬁrst trial, GH5, GH11, and GH45 coding sequences
were sub-cloned by restriction/ligation (R/L) into episomal
pBGP1 (Sasagawa et al., 2011) and integrative pGAPZαA and
pPICZαA expression vectors as described in Section “Materials
and Methods,” and recombinant expression was evaluated by
SDS-PAGE in the supernatant of culture media. Using integrative
vectors was expected to result in genetically stable P. pastoris
strains as they are integrated into the yeast chromosome at the
cost of more laborious screening, whereas an episomal vector
could be isolated by a simple plasmid preparation procedure.
In addition, episomal vectors have higher transformation
eﬃciencies and more than one copy per cell. It was therefore
of interest to assess whether these features were correlated to
recombinant protein expression level. Results are reported in
Figures 1A–C. Expression of GH5 and GH45 was plasmid-
dependant: GH5 was better expressed by pPICZαA than by
pGAPZαA whereas it was the opposite for GH45. No GH11
was visible in the culture medium of any plasmid condition. To
check whether GH11 was expressed, it was puriﬁed by aﬃnity
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FIGURE 1 | Expression results of different DNA constructs. (A–C), 25 μl of culture supernatant using the indicated expression plasmid were directly analyzed
by SDS-PAGE. (D) GH11 from (B) and (C) was purified by affinity chromatography on Ni-NTA, and 25 μl of elution fraction were analyzed by SDS-PAGE. M,
molecular weight markers. (A) 180, 130, 100, 70 ( ), 55 ( ), 40, 35, 25 ( ), 15, 10 kDa. (B–D) 250, 150, 100, 75 ( ), 50 ( ), 37, 25 ( ), 20, 10 kDa.
chromatography on Ni-NTA as described in Section “Materials
and Methods” and analyzed by SDS-PAGE (Figure 1D). GH11
was slightly better expressed by pPICZαA than by pGAPZαA,
although at levels deﬁnitely lower than those of GH5 and GH45.
On the basis of above results, integrative vectors pGAPZαA
and pPICZ were chosen for expressing fungal CAZymes. Two
attempts to make DNA constructs easier resulted in negative
expression results: the use of Gateway cloning instead of R/L
(Additional File 1), and the use of PCR to both generate and
linearize integrative expression constructs in a single experiment
(Liu et al., 2008; Yu et al., 2012) (Additional File 2). In conclusion,
the classical R/L technique followed by linearization by restriction
of expression integrative constructs before transformation was
used in the rest of this study, as proposed by Invitrogen
(easyselect_man.pdf).
Transformation
Frozen Electrocompetent Cells
Invitrogen advices not using frozen electrocompetent cells
because freeze/thaw cycles reduce cell transformation eﬃciency.
However, extemporaneously preparing electrocompetent cells is
time consuming, which proportionally increases the cost price
of recombinant proteins. The protocol used throughout this
study and described in Section “Materials and Methods” was
kindly provided by one of our collaborators (EIPL) and proved
successful with all our expression constructs. No attempt was
made to substitute electroporation with chemical transformation
because the transformation eﬃciency was considered too low
for the liquid phase transformation described below, although a
recently launched chemical compound (BG2) seems promising in
this respect (Filyak et al., 2013).
Amount of DNA for Transformation
As mentioned above, highest transformation eﬃciencies are not
required in a recombinant protein expression facility because
few clones are suﬃcient for expressing a recombinant protein.
Since the number of individual colonies on agar plates is
proportional to the amount of DNA used for transformation for
a given transformation eﬃciency, we assessed the possibility to
reduce the amount of DNA used for transformation. Invitrogen
protocol suggests using 10 μg of linear expression construct
per transformation. However, we found that as low as 0.5 μg
of linear expression construct was enough for obtaining the
necessary number of transformants for expressing recombinant
proteins. Incidentally, using less DNA also allows using plasmid
DNA mini-prep and not midi-prep kits, which is both faster
and cheaper. An additional gain of time could be to skip the
expression construct linearization by restriction, but we found
that electroporating yeast cells with 0.5 μg of non-linearized
integrative expression construct failed to give rise to colonies
on agar plates (not illustrated). In conclusion, 0.5 μg of linear
expression construct were decided to be, respectively, the default
value and DNA state used on the expression platform.
Plating-Free Transformation
Invitrogen’s protocol implies plating cells on Zeocin agar plates
after electroporation for selecting transformants. We reasoned
that there were no reason why transformants could not be
selected in liquid rather than in solid phase (i.e., on agar)
provided the selection reagent Zeocin was included in the culture
medium. Thereafter, we refer to selection of transformants
by plating on Zeocin-containing agar plates as “solid phase”
selection, and to selection of transformants by growing in YPD-
Zeocin as “liquid phase” selection. The only weakness of the
liquid phase option is that transformants are screened as a pool
and not as individual clones. As a consequence, the expression
screen result is the average of all clones that have been selected
by the antibiotic, which can lead to suboptimal expression
results.
We compared both approaches to assess whether having
individual clones was critical for our project. X33 cells were
transformed with linearized pGAPZαA constructs bearing
coding sequences for GH5, GH11, or GH45. After the sorbitol
step, 200 μl of cell suspension in sorbitol were plated and then
incubated at 30◦C for 3 days as usual, and another 200 μl of
the same cell suspension in sorbitol were used for liquid phase
selection as described in Section “Materials and Methods”. When
clones began to appear on agar, they were individually used to
inoculate 5 ml YPD-Zeocin and then allowed to grow and express
the recombinant protein for 4 days. Expression of recombinant
proteins of all solid and liquid phase experimental points
was assessed by assaying GH5, GH11, and GH45 enzymatic
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activities. Results (Figure 2) deﬁnitely show that, at least for
our three reference proteins, there was no diﬀerence between
either selection mean. In addition to using less Zeocin than solid
phase selection [2 μl in 2 ml YPD instead of 25 μl in 25 ml
YPD containing 1.2% agar (YPDA; i.e., the volume poured per
plate)], liquid phase selection does not preclude individual clones
to be selected on plate if necessary since it uses only 200 out of
1000 μl of the sorbitol suspension of transformed cells and so
an additional 200 μl aliquot can be plated and grown in parallel
with the liquid phase selection. In conclusion, the liquid phase
selection was chosen as default option for our facility because it
allows a yes/no answer to be obtained more quickly than solid
state screening. In case of negative or poor response, plated clones
can be used as a rescue.
Culture of Transformants
Culture Dish
Based on our experience in recombinant expression screening
in Escherichia coli (Noguere et al., 2012) and in ﬁlamentous
fungi (Alberto et al., 2009), the ANSI/SLAS (American National
Standards Institute/Society for Laboratory Automation and
Screening) format was preferred to classical tubes and ﬂasks for
growing cells. This format has two advantages. First, dishes stand
alone and do not require additional equipment such as tube or
ﬂask holders, which is convenient when many samples have to
be processed in parallel as it is often the case on a dedicated
platform. Second, it was devised for use with automates, which
allows for a direct transfer from culture incubators to robot
benchwork.
Although 96-wells deepwell plates have been successfully
used for growing and co-expressing recombinant proteins in
P. pastoris (Geier et al., 2013), 24-wells deepwell plates better
ﬁtted with the requirements of this type of platform. By
accommodating larger culture volumes than 96-wells deepwell
plates (5 instead of 1 ml per well), 24-wells deepwell plates
act as a magnifying tool of recombinant protein expression for
the following reason. Since recombinant proteins secreted by
P. pastoris in the culture medium are C-terminally His6-tagged,
they can be concentrated up to about 25 times by collecting
them by aﬃnity chromatography on Ni-NTA beads if elution
from the aﬃnity column is performed using 200 μl elution
buﬀer (see further). Hence, even tiny levels of expression can
be detected by SDS-PAGE analysis and Coomassie blue staining.
By contrast, each well of a 96-wells deepwell plates provides
ﬁve times less signal on gel for the same expression level
because it can accommodate only 1 ml of culture medium.
In addition, since oxygen transfer in 24-wells deepwell plates
is higher than in 96-wells deepwell plates (Duetz, 2007), one
may expect higher expression levels in the former than in
the latter. Baﬄed 16-wells deepwell plates used for growing
ﬁlamentous fungi (Alberto et al., 2009) were eventually not
considered for use on the platform because the number of wells
was too small for the intended screening throughput and their
geometry unﬁtted for the automate six needle pipetting arm.
In conclusion, 24-wells deepwell plates were chosen as default
culture dish.
Managing Zeocin Consumption
Yeast expression plasmids of pGAPZ and pPICZ series confer
Zeocin resistance to transformed cells, which allows for easy
selection of the latter after plating on Zeocin-containing agar
plates. However, Zeocin has two failings: it is expensive and
degrades rapidly with time. In particular, it is light sensitive.
Therefore, Zeocin-containing agar plates cannot be stored for
long periods of time before use and must be protected from light
throughout the process ranging from pouring to plating, which
makes their handling inconvenient.
We addressed the issues of cost and degradability by testing
the possibility of directly adding Zeocin to suspensions of
electroporated cells in sorbitol solution rather than to agar plates.
In practice, X33 cells were electroporated with episomal
Gateway plasmid pBGP1-DEST bearing GH5 coding sequence.
After the sorbitol step, 100 out of 1000 μl cell suspension
were spread on either a Zeocin plate made of 25 ml of YPDA
supplemented with 25 μl of 100 mg/ml Zeocin solution, or on
agar plates made of 25 ml of Zeocin-free YPDA. In the latter
FIGURE 2 | Plating is dispensable for expressing recombinant GH in Pichia pastoris. Liquid and solid phase selections were performed as described in the
results section. For the solid phase selection, three individual clones (numbered 1, 2, 3 on the x axis) were grown each in triplicate in individual wells of a 24-wells
deep-well plate. For the liquid phase selection, three individual wells (numbered 1, 2, 3 on the x axis) of a 24-wells deep-well were seeded each with 200 out of
1000 μl of the cell suspension in sorbitol solution after electroporation and assayed in triplicate. Results show the mean enzymatic activity assayed in culture
supernatants, with standard deviations of the triplicate assay.
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FIGURE 3 | Managing Zeocin consumption. The experiment was performed as described in the results section. After 4 days at 30◦C, plates were photographed.
In the upper row, Zeocin was added directly to the cell suspension before plating on Zeocin deficient plates. Numbers on top indicated the volume of Zeocin mother
solution added to 150 μl of cell suspension. The lonely plate below the upper row is the reference plate. In that case, the cell suspension was not supplemented with
Zeocin, but was plated on Zeocin-containing plate. This reference plate was located between plates “0” and “1” of the upper row because it roughly contained an
intermediate number of clones between these two plates.
FIGURE 4 | Antibiotics have no effect on P. pastoris growth nor on protein expression. (A) Effect of antibiotics on cell growth. The y axis is the optical density
of a 1/300 dilution of the culture. None, no antibiotic; Amp, 100 μg/ml ampicillin; Chlo, 34 μg/ml chloramphenicol; Kana, 50 μg/ml kanamycin; Tetra, 15 μg/ml
tetracycline; Zeo, 100 μg/ml Zeocin. (B) Recombinant proteins purified by affinity chromatography on Ni-NTA beads from 4 ml culture. From 100 μl of elution
volume, 15 μl were analyzed by SDS-PAGE along with 15 μl of non-purified supernatant (lanes S). M, molecular weight markers; from top to bottom: 116, 66.2, 45,
35, 25, 18.4, 14.4 kDa. Numbers 50, 100, 200 in lanes Chlo and Tetra indicate the volume in μl of 50% Ni-NTA beads suspension used. See results for details.
Frontiers in Microbiology | www.frontiersin.org 6 September 2015 | Volume 6 | Article 1002
Haon et al. P. pastoris expression platform
FIGURE 5 | Pichia pastoris recombinant protein expression platform.
Automated purification by affinity chromatography on Ni-NTA and enzymatic
activities assays of His6-tagged recombinant proteins are boxed. See Section
“Materials and Methods” for details.
case, cell suspensions were supplemented with 0, 1, 5, 10, or
25μl of 100mg/ml Zeocin solution immediately before spreading
on Zeocin-free plates. Plates were then incubated at 30◦C for
4 days, and the number of colonies was compared. Results
(Figure 3) indicate that adding 1 μl of Zeocin solution directly
to the cell suspension just before plating provided roughly
the same result as plating the same volume of the same cell
suspension on an agar plate supplemented with 25 μl of Zeocin
solution.
Adding Zeocin to the cell suspension immediately before
plating rather than in the agar plate allows (i) dividing Zeocin
consumption by about 50 for the same selection eﬃciency, (ii)
preparing YPDA plates in advance of use and then storing them
without particular caution except asepsis. In conclusion, if the
liquid phase selection described in a previous paragraph cannot
be performed because isolating clones is mandatory for some
reason, this can be done at lower cost and more conveniently
by adding Zeocin to the cell suspension just before plating rather
than in the YPDA plate.
Prevention of Bacterial Contamination
Because integrative plasmids are generally used for transforming
P. pastoris cells for which maintaining antibiotic selection
pressure after transformants have been selected is unnecessary,
and because the antibiotic used to select transformants (Zeocin)
is expensive, no antibiotic is used for growing clones thereafter.
Sometimes, however, the absence of antibiotic in rich culture
media such as YPD allows bacterial contaminations to occur
with the mandatory loss of the contaminated batch. Penicillin
and Streptomycin are routinely used to prevent bacterial
contaminations in eukaryotic cell line cultures. Being eukaryotes,
yeasts should not be sensitive to antibiotics commonly used
by microbiologists (ampicillin, chloramphenicol, kanamycin,
tetracycline), which could thus be added to the culture
medium without deleterious eﬀect while preventing such
contaminations.
To check that antibiotics had really no eﬀect on yeast growth,
a clone of P. pastoris cells expressing GH5 from pGAPZαA was
grown for 4 days in YPD in the presence or absence of the
antibiotics listed above at concentrations used in laboratories to
select resistant E. coli. Biomass was assessed by measuring the
optical density of the culture at 600 nm at the end of that period,
which deﬁnitely demonstrated the total innocuousness of this
series of antibiotics (Figure 4A). The amount of recombinant
protein secreted in the culture medium was next compared.
To that end, His6-tagged GH5 was concentrated by aﬃnity
chromatography on Ni-NTA beads under diﬀerent conditions
that are detailed in the next paragraph. Results (Figure 4B)
showed no diﬀerence between protein expression in the presence
or absence of antibiotic, suggesting that antibiotics have no
negative eﬀect on the over expression of a recombinant protein
in P. pastoris. In conclusion, if bacterial contaminations are an
issue commonly used antibiotics can provide good protection at
much lower cost than Zeocin, and without eﬀect on P. pastoris
cell growth or protein expression.
Protein Purification
Recombinant proteins were expressed as fusion proteins with
an N-terminal signal peptide and a C-terminal His6-tag. This
combination has two consequences. First, recombinant proteins
are secreted in the culture medium as are biomass-degrading
enzymes by ﬁlamentous fungi in their native environment.
Second, this diluted protein solution can be concentrated up
to about 25 times (compare, for example, lanes S to any
other lane in Figure 4B) by collecting tagged proteins by
aﬃnity chromatography on Ni-NTA beads. The latter has two
requirements: high speciﬁc binding is favored by slightly alkaline
pH (about 8), and low non-speciﬁc binding requires high salt
concentrations. Since YPD is devoid of any added salt and its
pH ≈6, the addition (Figure 4B) of 0.3 M NaCl with (lanes
N8) or without (lanes N) 100 mM Tris pH8 was compared
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to no addition (lanes 0). Results indicate that such additions
were not required. However, when the culture medium pH is
willingly maintained acidic (pH3) as in the fractional factorial
approach described in the next paragraph, buﬀering using a
ﬁnal concentration of 100 mM Tris pH8 is mandatory before
binding. The amount of Ni-NTA beads proved not limiting since
increasing them from 50 to 200 μl of a 50% beads suspension
did not increase the recovery yield (Figure 4B, lanes Chlo and
Tetra).
Since deepwell plates can be directly transferred from a
shaking incubator to a robot benchwork, the recovery of His6-
tagged recombinant proteins by aﬃnity chromatography on Ni-
NTA was automated. To that end, Ni-NTA beads were used
in deepwell ﬁlter plates as described in Section “Materials and
Methods.” Note that 100 μl of beads per well were used because
using 50 μl provided less reproducible results (not illustrated).
The ﬂowchart of the automated process is illustrated by Figure 5,
and a thorough description of the robot can be found in (Navarro
et al., 2010). After elution, recombinant His6-tagged proteins
were analyzed by gel electrophoresis using pre-cast gels, and by
assaying their enzymatic activity (Figure 6).
Expression Conditions
It is our experience that modifying expression parameters in
E. coli by trial and error is less eﬀective than testing the same
parameters in a factorial approach, mainly because parameter
interaction is lost in the former case (Benoit et al., 2007; Noguere
et al., 2012). Therefore, GH11 expression was tested in two
diﬀerent fractional factorial approaches using pGAPZαA and
pPICZαA vectors, respectively. A detailed description of the
method and of the results is in Additional File 3. In short, both
approaches converged to the conclusion that expression was
proportional to the temperature, and that an alkaline pH was
more favorable than an acidic one (Figure 6).
FIGURE 6 | Constitutive and inducible expression of a recombinant protein in P. pastoris using fractional factorial approaches. Recombinant GH11 was
purified by affinity chromatography on Ni-NTA as described in Section “Materials and Methods” and in Figure 5, and analyzed by SDS-PAGE and enzymatic assay.
(A) Constitutive expression using pGAPZαA. (B) Inducible expression using pPICZαA. Parameter value combinations of the fractional factorial approach are indicated
on top of each experimental point. Glu, Glucose; Gly, Glycerol; Sac, Saccharose; Sor, Sorbitol. M0.1, M1, M3, M10 stand for 0.1, 1, 3, 10% methanol concentration,
respectively. M, molecular weight markers (same as Figure 1A; GH11 migrates as the 40 kDa band). See Additional File 3 for details.
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FIGURE 7 | Comparative flowchart of Invitrogen (left) and our (right) protocol for expressing recombinant proteins in P. pastoris. In this example,
constitutive expression was chosen. Numbers on the left and on the right are the estimated number of days required by the considered step, with their sum (total) at
the bottom.
Conclusion
The recombinant protein production facility using P. pastoris
should avoid using episomal and/or Gateway vectors because
the former uselessly request maintaining expensive Zeocin
selection throughout the expression process, and the latter
failed at eﬃciently expressing three reference proteins. We
have observed that expressing three reference CAZymes was
plasmid-dependent. However, since testing both constitutive and
inducible expression in parallel might prove impractical for
large projects, a serial approach is more realistic. In case of
negative result, swapping plasmids is made easy by the identity of
cloning regions and reading frames of both vectors. Expression
constructs should better be made using classical R/L followed
by linearization by restriction. However, large projects may
require using synthetic genes with yeast-optimized codons. After
electroporation, transformants should be selected with Zeocin
in liquid phase as a pool and not as individual colonies on
agar plates. However, since electroporated cells can be stored for
weeks at 4◦C as sorbitol suspensions and only 200 μl out of
1000 are used for liquid phase selection, another 200 μl aliquot
should be plated in parallel to later screen for higher producers
(i.e., bearing gene multi-copies) if required. In addition, in
case of bacterial contamination it is possible to start a new
culture from liquid phase selection pre-culture (i.e., without
the need for another electroporation) in the presence of one
or more of the anti-microbial antibiotics tested in the present
study. For large projects, basic expression conditions (standard
culture media, 27◦C) are preferred in ﬁrst intention. By contrast,
fractional factorial approaches may be performed in case of single
protein project low expression yields and for high-added value
proteins. In the ANSI/SLAS format, 24-wells deepwell plates are
used for growing yeasts, liquid phase selection of transformants
and expression screening. Recombinant proteins secreted in the
culture medium are puriﬁed and concentrated by automated
aﬃnity chromatography on NiNTA beads.
A comparative ﬂowchart of the classical protocol set-up
by Invitrogen (pgapz_man.pdf) and of the simpliﬁed protocol
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TABLE 1 | The different enzymes expressed on the platform are reported.
Fungal strain CAZy
family
CBM Predicted activity Genbank ID cDNA
(bp)
Produced Yield Reference
Ustilago maydis GH3 – β-glucosidase 3634215 2619 No – –
Podospora anserina GH5 – β-1,4 mannanase 6194921 1236 Yes >100 Couturier et al., 2011a
P. anserina GH5 – β-1,4 mannanase 6187561 1388 No – –
P. anserina GH6 1 Cellobiohydrolase 6187194 1544 Yes >500 Poidevin et al., 2013
P. anserina GH6 – Endoglucanase 6187311 1319 Yes >500 Poidevin et al., 2013
P. anserina GH6 1 Cellobiohydrolase 6188027 1258 Yes >500 Poidevin et al., 2013
P. anserina GH10 1 β-1,4 xylanase 6188644 1387 No – –
P. anserina GH11 – β-1,4 xylanase 6197075 742 No – –
P. anserina GH11 1 β-1,4 xylanase 6187330 1060 Yes <100 Couturier et al., 2011a
P. anserina GH26 35 β-1,4 mannanase 6188179 1466 Yes >100 Couturier et al., 2011a
P. anserina GH27 – α-galactosidase 6195125 1370 No – –
U. maydis GH27 35 α-galactosidase 3632217 1719 No – –
P. anserina GH43 – β-xylosidase 6187343 1629 No – –
Pichia pastoris GH45 1 β-1,4 glucanase 8201351 1845 Yes >500 Couturier et al., 2011b
P. anserina GH51 – α-L-arabinofuranosidase 6188578 2251 Yes >100 Couturier et al., 2011a
U. maydis GH51 – α-L-arabinofuranosidase 3628887 2016 Yes >100 unpublished
U. maydis GH62 – α-L-arabinofuranosidase 3632410 996 Yes >100 Siguier et al., 2014
P. anserina GH62 – α-L-arabinofuranosidase 6188704 1068 Yes >100 Couturier et al., 2011a;
Siguier et al., 2014
P. anserina GH67 – α-glucuronidase 6189855 2591 No – –
P. anserina GH93 – arabinanase 6188440 1274 Yes >100 unpublished
P. anserina GH131 1 β-1,4 glucanase 6187659 1093 Yes >500 Lafond et al., 2012
Talaromyces
funiculosus
CE1 1 Cinnamoyl esterase AJ291496 1059 Yes n.d. unpublished
Penicillium
purpurogenum
CE1 1 Acetyl xylan esterase AF529173 1146 Yes n.d. unpublished
Volvariella volvacea CE1 1 Acetyl xylan esterase ABI63599 1047 Yes n.d. unpublished
Pycnoporus
cinnabarinus
CE1 1 Carbohydrate esterase (CE) CDO72503 1128 Yes n.d. unpublished
P. anserina CE15 1 Methylglucuronic esterase 6187208 1446 Yes <100 Katsimpouras et al.,
2014
P. anserina CE15 – Methylglucuronic esterase 6189833 1188 Yes <100 unpublished
P. anserina CE16 1 Acetyl esterase 6189799 1329 Yes <100 unpublished
U. maydis AA3_2 – GMC oxidoreductase 3632124 1911 Yes >500 unpublished
U. maydis AA3_2 – Glucose oxidase 3631645 1905 Yes >100 unpublished
P. anserina AA3_2 – Cellobiose dehydrogenase 6188032 2376 Yes >500 Bennati-Granier et al.,
2015
Pycnoporus
cinnabarinus
AA3_2 – Cellobiose dehydrogenase AF081574 4500 Yes >500 Bey et al., 2011
U. maydis AA5_1 – Glyoxal oxidase 3629211 1959 No – –
U. maydis AA5_1 – Glyoxal oxidase 3630482 2589 No – –
P. anserina AA9 1 Lytic polysaccharide monooxygenase 6195934 1056 Yes >100 Bey et al., 2013
P. anserina AA9 1 Lytic polysaccharide monooxygenase 6192283 1043 Yes >500 Bey et al., 2013
P. anserina AA9 – Lytic polysaccharide monooxygenase 6192256 783 No – –
P. anserina AA9 – lytic polysaccharide monooxygenase 6190208 1038 Yes >100 Bennati-Granier et al.,
2015
P. anserina AA9 1 Lytic polysaccharide monooxygenase 6191260 934 Yes <100 Bennati-Granier et al.,
2015
P. anserina AA9 – Lytic polysaccharide monooxygenase 6195000 902 Yes <100 Bennati-Granier et al.,
2015
P. anserina AA9 – Lytic polysaccharide monooxygenase 6196037 778 Yes <100 Bennati-Granier et al.,
2015
P. anserina AA9 1 Lytic polysaccharide monooxygenase 6187700 1113 Yes >100 Bennati-Granier et al.,
2015
Yield, amount of secreted recombinant protein (mg/L).
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described here for expressing biomass-degrading fungal enzymes
is provided in Figure 7. Overall, the simpliﬁed protocol allows
dividing by two the time required to go from transformation
to expression screening, and was used as a basis for setting-up
a recombinant protein production facility for the heterologous
expression of fungal CAZymes in P. pastoris (Figure 5). Table 1
summarizes all the results obtained using P. pastoris as host for
expressing fungal biomass-degrading enzymes in replacement of
native or recombinant expression in other fungi such a A. niger
and T. reesei (Levasseur et al., 2004; Poidevin et al., 2009).
Switching from the original Invitrogen protocol to the simpliﬁed
protocol described in this report and now routinely used on
the platform has resulted in an increased use of recombinant
expression in yeast from a few coding sequences in 2011 to
a total of more than 40 today, out of which more than 50%
were expressed at high level (>100 mg/L). The fungal CAZymes
functionally produced originate from several ﬁlamentous fungi
and belong to diﬀerent CAZy families within the GH, CE, andAA
classes. The platform is accessible to the community of CAZyme
users upon request.
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